These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7778129)

  • 1. The effect of cleavage by a Crotalus atrox alpha-proteinase fraction on the properties of C1-inhibitor.
    Patston PA; Qi M; Schifferli JA; Schapira M
    Toxicon; 1995 Jan; 33(1):53-61. PubMed ID: 7778129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary structure of the reactive site of human C1-inhibitor.
    Salvesen GS; Catanese JJ; Kress LF; Travis J
    J Biol Chem; 1985 Feb; 260(4):2432-6. PubMed ID: 3919001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
    Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
    J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats.
    de Smet BJ; de Boer JP; Agterberg J; Rigter G; Bleeker WK; Hack CE
    Blood; 1993 Jan; 81(1):56-61. PubMed ID: 8417802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
    de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
    J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1.
    Sulikowski T; Bauer BA; Patston PA
    Protein Sci; 2002 Sep; 11(9):2230-6. PubMed ID: 12192078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status.
    Skriver K; Wikoff WR; Patston PA; Tausk F; Schapira M; Kaplan AP; Bock SC
    J Biol Chem; 1991 May; 266(14):9216-21. PubMed ID: 2026621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 inhibitor hinge region mutations produce dysfunction by different mechanisms.
    Davis AE; Aulak K; Parad RB; Stecklein HP; Eldering E; Hack CE; Kramer J; Strunk RC; Bissler J; Rosen FS
    Nat Genet; 1992 Aug; 1(5):354-8. PubMed ID: 1363816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance between inhibition and substrate-type reactions of recombinant C1 inhibitor P5/P3 variants.
    Eldering E; Huijbregts CC; Nuijens JH; Hack CE
    Behring Inst Mitt; 1993 Dec; (93):125-30. PubMed ID: 8172559
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation, sequence analysis, and biological activity of atrolysin E/D, the non-RGD disintegrin domain from Crotalus atrox venom.
    Shimokawa K; Jia LG; Shannon JD; Fox JW
    Arch Biochem Biophys; 1998 Jun; 354(2):239-46. PubMed ID: 9637732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the serpin domain of C1 inhibitor.
    Coutinho M; Aulak KS; Davis AE
    J Immunol; 1994 Oct; 153(8):3648-54. PubMed ID: 7930585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence and biological activity of catrocollastatin-C: a disintegrin-like/cysteine-rich two-domain protein from Crotalus atrox venom.
    Shimokawa K; Shannon JD; Jia LG; Fox JW
    Arch Biochem Biophys; 1997 Jul; 343(1):35-43. PubMed ID: 9210644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of plasma kallikrein by C1-inhibitor: role of endothelial cells and the amino-terminal domain of C1-inhibitor.
    Ravindran S; Grys TE; Welch RA; Schapira M; Patston PA
    Thromb Haemost; 2004 Dec; 92(6):1277-83. PubMed ID: 15583734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikrein-like enzymes from Crotalus atrox venom.
    Bjarnason JB; Barish A; Direnzo GS; Campbell R; Fox JW
    J Biol Chem; 1983 Oct; 258(20):12566-73. PubMed ID: 6355088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence of a cDNA clone encoding the zinc metalloproteinase hemorrhagic toxin e from Crotalus atrox: evidence for signal, zymogen, and disintegrin-like structures.
    Hite LA; Shannon JD; Bjarnason JB; Fox JW
    Biochemistry; 1992 Jul; 31(27):6203-11. PubMed ID: 1378300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of multiple isoforms of alpha-fibrinogenase from the Western diamondback rattlesnake, Crotalus atrox: N-terminal sequence homology with ancrod, an antithrombotic agent from Malayan viper.
    Hung CC; Chiou SH
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1414-23. PubMed ID: 8024586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the complex between human alpha 2-macroglobulin and Crotalus adamanteus proteinase II. Release of active proteinase from the complex.
    Kress LF; Kurecki T
    Biochim Biophys Acta; 1980 Jun; 613(2):469-75. PubMed ID: 6160877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1-inhibitor-serine proteinase complexes and the biosynthesis of C1-inhibitor by Hep G2 and U 937 cells.
    Patston PA; Medcalf RL; Kourteva Y; Schapira M
    Blood; 1993 Dec; 82(11):3371-9. PubMed ID: 8241507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of hemorrhagic proteinase from Crotalus atrox (western diamondback rattlesnake) venom.
    Komori Y; Hagihara S; Tu AT
    Biochim Biophys Acta; 1985 May; 829(1):127-30. PubMed ID: 3888273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of plasma kallikrein with plasma proteinase inhibitors.
    Salvesen G; Virca GD; Travis J
    Adv Exp Med Biol; 1983; 156():121-30. PubMed ID: 6190363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.